Treatment Alternatives in Rare Disease; Assessment of Options in iSGS

• Research type

  Research Study

• Full title

  Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)

• IRAS ID

  198362

• Contact name

  Guri Sandhu

• Contact email

  Guri.Sandhu@imperial.nhs.uk

• Sponsor organisation

  Vanderbilt University

• Clinicaltrials.gov Identifier

  NCT02481817, https://clinicaltrials.gov/

• Duration of Study in the UK

  2 years, 1 months, 28 days

• Research summary

  The proposed study intends to create an international, multi-institutional prospective cohort of iSGS patients. It will enable rigorous treatment strategy comparisons to determine how well the most commonly used treatments in iSGS “work”; and what quality of life trade-offs are associated with each approach.

• REC name

  Yorkshire & The Humber - South Yorkshire Research Ethics Committee

• REC reference

  16/YH/0280

• Date of REC Opinion

  14 Jul 2016

• REC opinion

  Unfavourable Opinion